161 related articles for article (PubMed ID: 32922120)
1. Coculture model of blood-brain barrier on electrospun nanofibers.
Özyurt MG; Bayir E; DoĞan Ş; ÖztÜrk Ş; Şendemİr A
Turk J Biol; 2020; 44(4):121-132. PubMed ID: 32922120
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.
Qi D; Wu S; Lin H; Kuss MA; Lei Y; Krasnoslobodtsev A; Ahmed S; Zhang C; Kim HJ; Jiang P; Duan B
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21825-21835. PubMed ID: 29897225
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
4. Electrospun gelatin biopapers as substrate for in vitro bilayer models of blood-brain barrier tissue.
Bischel LL; Coneski PN; Lundin JG; Wu PK; Giller CB; Wynne J; Ringeisen BR; Pirlo RK
J Biomed Mater Res A; 2016 Apr; 104(4):901-9. PubMed ID: 26650896
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Drug Permeability Using
Ohshima M; Kamei S; Fushimi H; Mima S; Yamada T; Yamamoto T
Biores Open Access; 2019; 8(1):200-209. PubMed ID: 31737437
[TBL] [Abstract][Full Text] [Related]
6. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
7. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
[TBL] [Abstract][Full Text] [Related]
8. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.
Wevers NR; Kasi DG; Gray T; Wilschut KJ; Smith B; van Vught R; Shimizu F; Sano Y; Kanda T; Marsh G; Trietsch SJ; Vulto P; Lanz HL; Obermeier B
Fluids Barriers CNS; 2018 Aug; 15(1):23. PubMed ID: 30165870
[TBL] [Abstract][Full Text] [Related]
9. Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier.
Wang JD; Khafagy el-S; Khanafer K; Takayama S; ElSayed ME
Mol Pharm; 2016 Mar; 13(3):895-906. PubMed ID: 26751280
[TBL] [Abstract][Full Text] [Related]
10. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
11. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
Dhanikula RS; Argaw A; Bouchard JF; Hildgen P
Mol Pharm; 2008; 5(1):105-16. PubMed ID: 18171013
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an in vitro coculture model for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources.
Scism JL; Laska DA; Horn JW; Gimple JL; Pratt SE; Shepard RL; Dantzig AH; Wrighton SA
In Vitro Cell Dev Biol Anim; 1999; 35(10):580-92. PubMed ID: 10614867
[TBL] [Abstract][Full Text] [Related]
14. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug.
Gaillard PJ; de Boer AG
Eur J Pharm Sci; 2000 Dec; 12(2):95-102. PubMed ID: 11102736
[TBL] [Abstract][Full Text] [Related]
15. Communication from the periphery to the hypothalamus through the blood-brain barrier: An in vitro platform.
Martins JP; Alves CJ; Neto E; Lamghari M
Int J Pharm; 2016 Feb; 499(1-2):119-130. PubMed ID: 26732523
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Blood-brain Barrier and Simulated metabolic system on Apoptosis of SH-SY5Y Induced by Acrylamide in Vitro].
Chen X; Zhu D; Yang YG; Li ZS; Zhang Y; Xiao JW; Li B
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Jun; 36(6):401-407. PubMed ID: 30248731
[No Abstract] [Full Text] [Related]
17. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB).
Booth R; Kim H
Lab Chip; 2012 Apr; 12(10):1784-92. PubMed ID: 22422217
[TBL] [Abstract][Full Text] [Related]
19. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
Jiang L; Chen J; He Y; Zhang Y; Li G
J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
[TBL] [Abstract][Full Text] [Related]
20. Development of a blood-brain barrier model in a membrane-based microchip for characterization of drug permeability and cytotoxicity for drug screening.
Shao X; Gao D; Chen Y; Jin F; Hu G; Jiang Y; Liu H
Anal Chim Acta; 2016 Aug; 934():186-93. PubMed ID: 27506359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
